Zobrazeno 1 - 10
of 247 517
pro vyhledávání: '"NEUTRALIZING ANTIBODIES"'
Autor:
de Taeye SW; Amsterdam UMC location University of Amsterdam, Department of Medical Microbiology, Meibergdreef 9, Amsterdam, The Netherlands. s.w.detaeye@amsterdamumc.nl.; Amsterdam Institute for Immunology and Infectious diseases, Infectious diseases, Amsterdam, The Netherlands. s.w.detaeye@amsterdamumc.nl., Schriek AI; Amsterdam UMC location University of Amsterdam, Department of Medical Microbiology, Meibergdreef 9, Amsterdam, The Netherlands.; Amsterdam Institute for Immunology and Infectious diseases, Infectious diseases, Amsterdam, The Netherlands., Umotoy JC; Amsterdam UMC location University of Amsterdam, Department of Medical Microbiology, Meibergdreef 9, Amsterdam, The Netherlands.; Amsterdam Institute for Immunology and Infectious diseases, Infectious diseases, Amsterdam, The Netherlands., Grobben M; Amsterdam UMC location University of Amsterdam, Department of Medical Microbiology, Meibergdreef 9, Amsterdam, The Netherlands.; Amsterdam Institute for Immunology and Infectious diseases, Infectious diseases, Amsterdam, The Netherlands., Burger JA; Amsterdam UMC location University of Amsterdam, Department of Medical Microbiology, Meibergdreef 9, Amsterdam, The Netherlands.; Amsterdam Institute for Immunology and Infectious diseases, Infectious diseases, Amsterdam, The Netherlands., Sanders RW; Amsterdam UMC location University of Amsterdam, Department of Medical Microbiology, Meibergdreef 9, Amsterdam, The Netherlands.; Amsterdam Institute for Immunology and Infectious diseases, Infectious diseases, Amsterdam, The Netherlands.; Weill Medical College of Cornell University, Department of Microbiology and Immunology, New York, NY, 10065, USA., Vidarsson G; Sanquin Research and Landsteiner, Amsterdam UMC location University of Amsterdam, Immunoglobulin Research Laboratory, Department of Experimental Immunohematology, 1066 CX, Amsterdam, The Netherlands.; Department of Biomolecular Mass Spectrometry and Proteomics, Utrecht Institute for Pharmaceutical Sciences and Bijvoet Center for Biomolecular Research, Utrecht University, Utrecht, The Netherlands., Wuhrer M; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands., Falck D; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands., Kootstra NA; Amsterdam UMC location University of Amsterdam, Department of Medical Microbiology, Meibergdreef 9, Amsterdam, The Netherlands.; Amsterdam UMC location University of Amsterdam, Department of Experimental Immunology, Meibergdreef 9, Amsterdam, The Netherlands., van Gils MJ; Amsterdam UMC location University of Amsterdam, Department of Medical Microbiology, Meibergdreef 9, Amsterdam, The Netherlands. m.j.vangils@amsterdamumc.nl.; Amsterdam Institute for Immunology and Infectious diseases, Infectious diseases, Amsterdam, The Netherlands. m.j.vangils@amsterdamumc.nl.
Publikováno v:
Communications biology [Commun Biol] 2024 Aug 09; Vol. 7 (1), pp. 964. Date of Electronic Publication: 2024 Aug 09.
Autor:
Walimbwa, Stephen Ian1 (AUTHOR) Stephenian.walimbwa01@upol.cz, Maly, Petr2 (AUTHOR), Kafkova, Leona Raskova3 (AUTHOR), Raska, Milan1,3 (AUTHOR) milan.raska@upol.cz
Publikováno v:
Journal of Biomedical Science. 8/21/2024, Vol. 31 Issue 1, p1-16. 16p.
Autor:
Gai, Yanxin1 (AUTHOR) gaiyx20@mails.jlu.edu.cn, Gao, Nan1 (AUTHOR) gaonan15@mails.jlu.edu.cn, Mou, Zhaoyang1 (AUTHOR) mouzy22@mails.jlu.edu.cn, Yang, Chumeng1 (AUTHOR) yangcm1319@mails.jlu.edu.cn, Wang, Libian1 (AUTHOR) lbwang22@mails.jlu.edu.cn, Ji, Wanshan1 (AUTHOR) jiws21@mails.jlu.edu.cn, Gu, Tiejun1 (AUTHOR) gutj@jlu.edu.cn, Yu, Bin1 (AUTHOR) yubin@jlu.edu.cn, Wang, Chu1 (AUTHOR) wangchu18@jlu.edu.cn, Yu, Xianghui1,2 (AUTHOR) xianghui@jlu.edu.cn, Gao, Feng1,3,4 (AUTHOR) xianghui@jlu.edu.cn
Publikováno v:
International Journal of Molecular Sciences. Jul2024, Vol. 25 Issue 13, p7200. 20p.
Autor:
Goh, Vanessa Shi Li1 (AUTHOR), Ang, Christopher Chong Wei1 (AUTHOR), Low, Swee Ling1 (AUTHOR), Lee, Pei Xuan1 (AUTHOR), Setoh, Yin Xiang1,2,3 (AUTHOR), Wong, Judith Chui Ching1 (AUTHOR) Judith_WONG@nea.gov.sg
Publikováno v:
Virology Journal. 9/3/2024, Vol. 21 Issue 1, p1-10. 10p.
Autor:
Cui L; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, School of Life Sciences, Xiamen University, Xiamen 361102, China.; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Collaborative Innovation Center of Biologic Products, National Innovation Platform for Industry-Education Integration in Vaccine Research, The Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen 361102, China., Li T; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, School of Life Sciences, Xiamen University, Xiamen 361102, China.; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Collaborative Innovation Center of Biologic Products, National Innovation Platform for Industry-Education Integration in Vaccine Research, The Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen 361102, China., Xue W; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, School of Life Sciences, Xiamen University, Xiamen 361102, China.; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Collaborative Innovation Center of Biologic Products, National Innovation Platform for Industry-Education Integration in Vaccine Research, The Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen 361102, China., Zhang S; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, School of Life Sciences, Xiamen University, Xiamen 361102, China.; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Collaborative Innovation Center of Biologic Products, National Innovation Platform for Industry-Education Integration in Vaccine Research, The Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen 361102, China., Wang H; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, School of Life Sciences, Xiamen University, Xiamen 361102, China.; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Collaborative Innovation Center of Biologic Products, National Innovation Platform for Industry-Education Integration in Vaccine Research, The Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen 361102, China., Liu H; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, School of Life Sciences, Xiamen University, Xiamen 361102, China.; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Collaborative Innovation Center of Biologic Products, National Innovation Platform for Industry-Education Integration in Vaccine Research, The Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen 361102, China., Gu Y; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, School of Life Sciences, Xiamen University, Xiamen 361102, China.; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Collaborative Innovation Center of Biologic Products, National Innovation Platform for Industry-Education Integration in Vaccine Research, The Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen 361102, China., Xia N; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, School of Life Sciences, Xiamen University, Xiamen 361102, China.; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Collaborative Innovation Center of Biologic Products, National Innovation Platform for Industry-Education Integration in Vaccine Research, The Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen 361102, China., Li S; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, School of Life Sciences, Xiamen University, Xiamen 361102, China.; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Collaborative Innovation Center of Biologic Products, National Innovation Platform for Industry-Education Integration in Vaccine Research, The Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen 361102, China.
Publikováno v:
Viruses [Viruses] 2024 Jun 01; Vol. 16 (6). Date of Electronic Publication: 2024 Jun 01.
Autor:
Rai MA; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, MD, USA., Blazkova J; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, MD, USA., Justement JS; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, MD, USA., Shi V; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, MD, USA., Kennedy BD; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, MD, USA., Manning MR; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, MD, USA., McLaughlin M; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, MD, USA., Sneller MC; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, MD, USA., Pau AK; Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, MD, USA., Moir S; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, MD, USA., Chun TW; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, MD, USA. Electronic address: twchun@nih.gov.
Publikováno v:
EBioMedicine [EBioMedicine] 2024 Jun; Vol. 104, pp. 105151. Date of Electronic Publication: 2024 May 09.
Autor:
Arbi, Marwa1 (AUTHOR) marwa.arbi@pasteur.utm.tn, Khedhiri, Marwa2,3,4 (AUTHOR), Ayouni, Kaouther2,3,4 (AUTHOR), Souiai, Oussema1,5 (AUTHOR), Dhouib, Samar6 (AUTHOR), Ghanmi, Nidhal1 (AUTHOR), Benkahla, Alia1 (AUTHOR), Triki, Henda2,3,4 (AUTHOR), Haddad-Boubaker, Sondes2,3,4 (AUTHOR)
Publikováno v:
Evolutionary Bioinformatics. 8/14/2024, p1-14. 14p.
Autor:
Xie Z; The Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA., Lin YC; The Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA., Steichen JM; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA., Ozorowski G; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA., Kratochvil S; The Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA., Ray R; The Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA., Torres JL; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA., Liguori A; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA., Kalyuzhniy O; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA., Wang X; The Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA., Warner JE; The Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA., Weldon SR; The Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA., Dale GA; The Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA., Kirsch KH; The Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA., Nair U; The Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA., Baboo S; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA., Georgeson E; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA., Adachi Y; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA., Kubitz M; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA., Jackson AM; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA., Richey ST; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA., Volk RM; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA., Lee JH; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA., Diedrich JK; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA., Prum T; The Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA., Falcone S; Moderna Inc., Cambridge, MA 02139, USA., Himansu S; Moderna Inc., Cambridge, MA 02139, USA., Carfi A; Moderna Inc., Cambridge, MA 02139, USA., Yates JR 3rd; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA., Paulson JC; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA., Sok D; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA., Ward AB; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA., Schief WR; The Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA.; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA.; Moderna Inc., Cambridge, MA 02139, USA., Batista FD; The Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Publikováno v:
Science (New York, N.Y.) [Science] 2024 May 17; Vol. 384 (6697), pp. eadk0582. Date of Electronic Publication: 2024 May 17.
Autor:
Wang X; Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA., Cottrell CA; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, Scripps Research Institute, La Jolla, CA 92037, USA., Hu X; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, Scripps Research Institute, La Jolla, CA 92037, USA.; Moderna Inc., Cambridge, MA 02139, USA., Ray R; Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA., Bottermann M; Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA., Villavicencio PM; Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA., Yan Y; Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA., Xie Z; Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA., Warner JE; Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA., Ellis-Pugh JR; Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA., Kalyuzhniy O; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, Scripps Research Institute, La Jolla, CA 92037, USA., Liguori A; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, Scripps Research Institute, La Jolla, CA 92037, USA., Willis JR; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, Scripps Research Institute, La Jolla, CA 92037, USA., Menis S; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, Scripps Research Institute, La Jolla, CA 92037, USA., Rämisch S; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, Scripps Research Institute, La Jolla, CA 92037, USA., Eskandarzadeh S; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, Scripps Research Institute, La Jolla, CA 92037, USA., Kubitz M; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, Scripps Research Institute, La Jolla, CA 92037, USA., Tingle R; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, Scripps Research Institute, La Jolla, CA 92037, USA., Phelps N; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, Scripps Research Institute, La Jolla, CA 92037, USA., Groschel B; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, Scripps Research Institute, La Jolla, CA 92037, USA., Himansu S; Moderna Inc., Cambridge, MA 02139, USA., Carfi A; Moderna Inc., Cambridge, MA 02139, USA., Kirsch KH; Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA., Weldon SR; Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA., Nair U; Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA., Schief WR; Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, Scripps Research Institute, La Jolla, CA 92037, USA.; Moderna Inc., Cambridge, MA 02139, USA., Batista FD; Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Publikováno v:
Science immunology [Sci Immunol] 2024 May 10; Vol. 9 (95), pp. eadn0622. Date of Electronic Publication: 2024 May 16.
Autor:
Parthasarathy D; Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, MN, USA., Pothula KR; Duke Human Vaccine Institute, Duke University, Durham, NC, USA., Ratnapriya S; Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, MN, USA., Cervera Benet H; Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, MN, USA., Parsons R; Duke Human Vaccine Institute, Duke University, Durham, NC, USA.; Department of Biochemistry, Duke University, Durham, NC, USA., Huang X; Duke Human Vaccine Institute, Duke University, Durham, NC, USA., Sammour S; Duke Human Vaccine Institute, Duke University, Durham, NC, USA., Janowska K; Duke Human Vaccine Institute, Duke University, Durham, NC, USA., Harris M; Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, MN, USA., Sodroski J; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Microbiology, Harvard Medical School, Boston, MA, USA., Acharya P; Duke Human Vaccine Institute, Duke University, Durham, NC, USA.; Department of Biochemistry, Duke University, Durham, NC, USA.; Department of Surgery, Duke University, Durham, NC, USA., Herschhorn A; Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, MN, USA. aherschh@umn.edu.; Institute for Molecular Virology, University of Minnesota, University of Minnesota, Minneapolis, MN, USA. aherschh@umn.edu.; Microbiology, Immunology, and Cancer Biology Graduate Program, University of Minnesota, Minneapolis, MN, USA. aherschh@umn.edu.; The College of Veterinary Medicine Graduate Program, University of Minnesota, Minneapolis, MN, USA. aherschh@umn.edu.; Molecular Pharmacology and Therapeutics Graduate Program, University of Minnesota, Minneapolis, MN, USA. aherschh@umn.edu.
Publikováno v:
Nature communications [Nat Commun] 2024 Aug 26; Vol. 15 (1), pp. 7334. Date of Electronic Publication: 2024 Aug 26.